权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

System for Annulus Fibrosus Repair (SAFR) – a percutaneously implantable preformed biomaterial for the repair of defects caused by either degenerative disc disease or needle puncture during nucleus pulposus replacement procedures SAFR

纤维环修复系统 (SAFR) — 一种可经皮植入的预制生物材料，用于修复髓核置换手术期间因椎间盘退行性疾病或针刺造成的缺陷

基本信息

批准号：
10051703
负责人：
金额：
$ 189.4万
依托单位：
ORTHOSON LIMITED
依托单位国家：
英国
项目类别：
Collaborative R&D
财政年份：
2023
资助国家：
英国
起止时间：
2023 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=10051703
关键词：
System Annulus Fibrosus Repair SAFR

项目摘要

The SAFR seeks to address the existing market challenge for an annulus fibrosus repair device to prevent the extrusion of nucleus pulposus material that occurs during any minimally invasive discectomy treatment or surgical needle puncture to the Annulus Fibrosus. OrthoSon aims to bring to market an innovative, disruptively simple solution of UK origin that enables the repair of these annulus fibrosus defects with a much greater efficacy rate than is currently available from competitor technology today and at a lower cost.OrthoSon is a rapidly developing, well-funded company, spun out of the University of Oxford with a mission to alleviate back pain, the largest cause of global disability, by using technology to restore the degenerated intervertebral disc. SAFR is a new product, complementary to OrthoSon's mission, that addresses another global clinical unmet need.With OrthoSon as lead and responsible for the overall development and commercialisation of the device, project partners Imperial College London, leveraging their specialist spinal implant testing facility, will develop the testing process and evaluate findings; while East Midlands Spine, a specialist spinal treatment and consultancy company, will provide clinical input on device design.

SAFR旨在解决纤维环修复器械的现有市场挑战，以防止在任何微创椎间盘切除术治疗或手术针穿刺纤维环期间发生髓核材料挤出。OrthoSon旨在将一种创新的、颠覆性的、简单的、源于英国的解决方案推向市场，使这些纤维环缺陷的修复具有比目前竞争对手技术更高的效率，并且成本更低。OrthoSon是一家发展迅速、资金充足的公司，从牛津大学分离出来，使命是减轻背痛，这是全球残疾的最大原因，通过技术手段来恢复退变的椎间盘。SAFR是一种新产品，补充了OrthoSon的使命，解决了另一个全球临床未满足的需求。由OrthoSon领导并负责该设备的整体开发和商业化，项目合作伙伴伦敦帝国理工学院伦敦，利用其专业的脊柱植入物测试设施，将开发测试过程并评估结果;而东米德兰兹脊柱，一家专业的脊柱治疗和咨询公司，将提供设备设计的临床输入。